Katia Jessica Flores Aparco
KATIA FLORESKATIA FLORES

Katia Jessica Flores Aparco

FACULTATIU ESPECIALISTA HEMATOLOGIA I HEMOTERAPIA

Dades destacades

  • Última publicació:
    Effectiveness and Safety of Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Patients with Active Cancer Therapy and Non Valvular Atrial Fibrillation

Dades del professional

Hospital Universitari General de Catalunya
FACULTATIU ESPECIALISTA HEMATOLOGIA I HEMOTERÀPIA
Octubre 2022 - Actualitat
Hospital Universitari Sagrat Cor
FACULTATIU ESPECIALISTA HEMATOLOGIA I HEMOTERÀPIA
Octubre 2022 - Actualitat
Hospital Universitari Gral. de Catalunya
Tutor clínic Universitari
Gener 2018 - Gener 2022
Hospital Universitari Gral. de Catalunya
Facultatiu/iva esp.
Gener 2017 - Gener 2022
Estudi
Llicenciada en Medicina
universitat, Universidad Nacional Federico Villarreal
2011
Una altra titulació
Curs de Citologia Hematològica
hospital
Una altra titulació
Especialitat d'hematologia i hemoteràpia
hospital
1r taller de citologia hematològica
Hospital Universitari General de Catalunya
Gener 2019 - Gener 2019
RIETE: Association between reperfusion therapy and outcomes in patients with acute pulmonary embolism and right heart thrombic
RIETE: Timing and characteristics of venous thromboembolism after noncancer surgery
RIETE: Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism
RIETE: Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism
RIETE: Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis
RIETE: Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
Effectiveness and Safety of Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Patients with Active Cancer Therapy and Non Valvular Atrial Fibrillation
Natural history of patients with venous thromboembolism and hereditary haemorrhagic telangiectasia. Findings from the RIETE registry
Predicting the risk for major bleeding in elderly patients with venous thromboembolism using the Charlson index. Findings from the RIETE
RIETE: Association between reperfusion therapy and outcomes in patients with acute pulmonary embolism and right heart thrombic
RIETE: Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis
RIETE: Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
RIETE: Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism
RIETE: Rivaroxaban or apixaban in fragile patients with acute venous thromboembolism
RIETE: Timing and characteristics of venous thromboembolism after noncancer surgery
Demana cita amb aquest professional

Articles de

Consulta els darrers articles a Tu canal de salud.

Consulta el contenido multimedia de este profesional.

mockup_mi_quironsalud@2x_recortadamockup_mi_quironsalud@2x_recortada

Àrea personal de salut: Mi Quirónsalud

Accedeix a qualsevol hora del dia per tenir cura de la teva salut i la dels teus.

Mi Quirónsalud és el teu espai personal privat i segur, on pots sol·licitar i gestionar les teves cites o consultar els teus informes clínics sense esperes ni desplaçaments.
Descobreix-ho!